Marriott Vacations (VAC) Q2 2026 Earnings Call Transcript

Marriott Vacations reported Q2 contract sales up 22% YoY to $545 million and Adjusted EBITDA up 6% YoY to $215 million, exceeding guidance and driving $87 million of adjusted free cash flow in the quarter ($201 million year-to-date vs $22 million in 1H 2025). The company raised full-year 2026 Adjusted EBITDA guidance to $805 million–$830 million (+$50 million vs prior), increased full-year Adjusted Free Cash Flow to $410 million–$460 million (+$35 million at the midpoint), and lifted contract sales growth guidance to 18%–20%. Leverage fell to ~4.0x from 4.2x, with net corporate debt at $3.1 billion, and management indicated share repurchases/dividends become more opportunistic as leverage moves toward the upper-3x area by year-end.

Analysis

The key market implication is not the headline growth rate; it is that management appears to have found a levered operating model that can reaccelerate without materially expanding inventory. That matters because every incremental point of EBITDA should translate into faster equity deleveraging and, once leverage dips below 4x, a credible path to buybacks that can re-rate VAC well before the underlying unit growth becomes truly durable.

The second-order winner is the branded-hotel channel around Marriott/Hyatt: if VAC can consistently monetize that database and hotel-footfall funnel, it increases the value of the parent brands’ loyalty ecosystems and creates a higher-ARPU acquisition channel that smaller peers cannot easily replicate. The losers are HGV and TNL, which face a tougher relative-growth comparison if VAC’s owner-upgrade strategy and experiential events keep lifting transaction size; that said, this is more a margin-and-mix story than a broad demand boom, so competitors with less leverage may still outperform on durability.

Contrarian risk: the market may be over-crediting price/aspiration effects while underweighting what happens when the consumer softens. The growth engine is increasingly dependent on higher ticket sizes, financing mix, and reserve discipline, so the first place the thesis breaks is not tour counts but conversion quality, delinquencies, and reportability if sales are pulled forward into quarter-end. The near-term catalyst is another clean quarter of July/August momentum; the medium-term catalyst is proof that the new channels can sustain 1-3% tour growth and keep leverage moving toward the buyback threshold.

What would falsify the bull case is a Q3 guide cut, a step-up in loan-loss provisioning, or leverage failing to move below 4x by year-end despite the EBITDA raise. If any of those happen, the market will likely reprice VAC back toward a highly levered cyclical rather than a self-help compounder.

Key Decisions for Investors

• Buy VAC on pullbacks over the next 1-2 sessions; base case is a continued rerating if the market believes the second-half run-rate is real, with 12-18 month upside tied to deleveraging and eventual buybacks.
• Pair trade: long VAC / short TNL over 1-3 months. VAC has the cleaner near-term self-help catalyst and more visible path to capital returns; TNL is more exposed to a slower-moving membership/exchange narrative.
• If the stock gaps sharply higher, use a call-spread structure instead of chasing common: buy VAC 3-6 month call spreads to express the EBITDA-deleveraging thesis with defined downside.
• Set a risk alert on VAC if delinquencies or loan-loss reserves tick up again next quarter; that would be the first sign the higher transaction-size story is becoming credit-sensitive.
• Trim or hedge the long if management does not reiterate sub-4x leverage progress by year-end; that is the key threshold for multiple expansion and buyback optionality.